Published in Neuropsychol Rev on March 01, 2006
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord (2012) 1.73
How do you (estimate you will) like them apples? Integration as a defining trait of orbitofrontal function. Curr Opin Neurobiol (2010) 1.13
Interactions between the prefrontal cortex and amygdala during delay discounting and reversal. Behav Neurosci (2009) 1.13
The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition. Pharmacol Biochem Behav (2013) 1.11
Abnormal corticostriatal-limbic functional connectivity in obsessive-compulsive disorder during reward processing and resting-state. Neuroimage Clin (2013) 1.02
Altered cingulate sub-region activation accounts for task-related dissociation in ERN amplitude as a function of obsessive-compulsive symptoms. Neuropsychologia (2010) 0.92
A further evaluation of decision-making under risk and under ambiguity in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2012) 0.92
Antisaccade performance in patients with obsessive-compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype. Eur Arch Psychiatry Clin Neurosci (2012) 0.88
Gray matter structural alterations in obsessive-compulsive disorder: relationship to neuropsychological functions. Psychiatry Res (2008) 0.84
Abnormal resting-state activities and functional connectivities of the anterior and the posterior cortexes in medication-naïve patients with obsessive-compulsive disorder. PLoS One (2013) 0.83
Commentary on: Muscle dysmorphia: could it be classified as an addiction to body image? J Behav Addict (2015) 0.83
Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. BMJ Case Rep (2011) 0.81
The impact of cafeteria diet feeding on physiology and anxiety-related behaviour in male and female Sprague-Dawley rats of different ages. Pharmacol Biochem Behav (2013) 0.78
Cognitive deficits in patients with obsessive-compulsive disorder - electroencephalography correlates. Neuropsychiatr Dis Treat (2016) 0.75
Deep brain stimulation for the treatment of severe, medically refractory obsessive-compulsive disorder. Perm J (2013) 0.75
Modulation of motor inhibition by subthalamic stimulation in obsessive-compulsive disorder. Transl Psychiatry (2016) 0.75
Cool and Hot Aspects of Executive Function in Childhood Obsessive-Compulsive Disorder. J Abnorm Child Psychol (2016) 0.75
Is nocturnal eating in restless legs syndrome linked to a specific psychopathological profile? A pilot study. J Neural Transm (Vienna) (2015) 0.75
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry (2002) 1.65
Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet (2004) 1.20
A P5 cancer medicine approach: why personalized medicine cannot ignore psychology. J Eval Clin Pract (2011) 1.17
P5 medicine: a plus for a personalized approach to oncology. Nat Rev Clin Oncol (2011) 1.17
Virtual worlds, real healing. Science (2007) 1.14
Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet (2005) 1.13
Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype. Biol Psychiatry (2010) 1.11
Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study. Biol Psychiatry (2003) 1.09
Neuropsychological investigation of decision-making in anorexia nervosa. Psychiatry Res (2004) 1.08
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage (2008) 1.08
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Eur Neuropsychopharmacol (2005) 1.07
Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet (2002) 1.07
Virtual reality on mobile phones to reduce anxiety in outpatient surgery. Stud Health Technol Inform (2009) 1.02
Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Clin Psychiatry (2007) 0.97
Can relaxation training reduce emotional eating in women with obesity? An exploratory study with 3 months of follow-up. J Am Diet Assoc (2009) 0.97
Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study. Biol Psychiatry (2002) 0.95
Approximate entropy of respiratory patterns in panic disorder. Am J Psychiatry (2004) 0.94
Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: a European multicenter study. Drug Alcohol Depend (2008) 0.91
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
NeuroVR 1.5 in Practice: Actual Clinical Applications of the Open Source VR System. Stud Health Technol Inform (2009) 0.89
Self-injurious behavior and attempted suicide in purging bulimia nervosa: associations with psychiatric comorbidity. J Affect Disord (2007) 0.89
Interreality in practice: bridging virtual and real worlds in the treatment of posttraumatic stress disorders. Cyberpsychol Behav Soc Netw (2010) 0.88
Executive functioning in anorexia nervosa patients and their unaffected relatives. Psychiatry Res (2012) 0.88
Low social interactions in eating disorder patients in childhood and adulthood: a multi-centre European case control study. J Health Psychol (2012) 0.88
Fat mass and obesity-associated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with bulimia nervosa and anorexia nervosa. Obes Facts (2012) 0.87
Investigation of the serotonin transporter regulatory region polymorphism in bulimia nervosa: relationships to harm avoidance, nutritional parameters, and psychiatric comorbidity. Psychosom Med (2006) 0.87
Neurosteroid secretion in panic disorder. Psychiatry Res (2003) 0.87
Smoking and respiratory irregularity in panic disorder. Biol Psychiatry (2004) 0.87
Decision-making functioning as a predictor of treatment outcome in anorexia nervosa. Psychiatry Res (2006) 0.86
Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome. J Clin Psychopharmacol (2002) 0.86
Motor inhibition and cognitive flexibility in eating disorder subtypes. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.85
The effect of social content on deductive reasoning: an fMRI study. Hum Brain Mapp (2005) 0.85
Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology (2005) 0.85
The Intrepid project - biosensor-enhanced virtual therapy for the treatment of generalized anxiety disorders. Stud Health Technol Inform (2009) 0.84
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients. Neuropsychopharmacology (2006) 0.84
NeuroVR 1.5 - a free virtual reality platform for the assessment and treatment in clinical psychology and neuroscience. Stud Health Technol Inform (2009) 0.83
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. Int Clin Psychopharmacol (2009) 0.83
Artificial neural network model for the prediction of obsessive-compulsive disorder treatment response. J Clin Psychopharmacol (2009) 0.82
Anticipation of age at onset of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder. Psychiatry Res (2002) 0.81
Respiration in children at risk for panic disorder. Arch Gen Psychiatry (2002) 0.81
Novel antidepressants and panic disorder: evidence beyond current guidelines. Neuropsychobiology (2010) 0.81
Cardiorespiratory response to physical exercise and psychological variables in panic disorder. Rev Bras Psiquiatr (2011) 0.80
The use of biofeedback in clinical virtual reality: the INTREPID project. J Vis Exp (2009) 0.80
The use of biofeedback in clinical virtual reality: the intrepid project. Stud Health Technol Inform (2009) 0.80
Case-control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. Psychiatr Genet (2006) 0.80
Mirroring avatars: dissociation of action and intention in human motor resonance. Eur J Neurosci (2011) 0.80
The somatic marker affecting decisional processes in obsessive-compulsive disorder. Cogn Neuropsychiatry (2011) 0.79
No association between obsessive-compulsive disorder and the 5-HT(1Dbeta) receptor gene. Am J Psychiatry (2002) 0.78
Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study. J Clin Psychopharmacol (2004) 0.78
The advantages of choosing antiobsessive therapy according to decision-making functioning. J Clin Psychopharmacol (2004) 0.77
Anxiety sensitivity and 35% CO2 reactivity in patients with panic disorder. J Psychosom Res (2003) 0.77
Serotonergic modulation of the balance system in panic disorder: an open study. Depress Anxiety (2003) 0.77
Clinical Trials, Data Protection and Patient Empowerment in the Era of the New EU Regulations. Public Health Genomics (2015) 0.77
Selective serotonin re-uptake inhibitors beyond psychiatry: are they useful in the treatment of severe, chronic, obstructive pulmonary disease? Depress Anxiety (2004) 0.76
Supporting tools in psychiatric treatment decision-making: sertraline outcome investigation with artificial neural network method. Psychiatry Res (2005) 0.76
Comparison of 35% carbon dioxide reactivity between panic disorder and eating disorder. Psychiatry Res (2004) 0.76
Novel 5'-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder. Int J Neuropsychopharmacol (2000) 0.76
Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder. Am J Med Genet B Neuropsychiatr Genet (2004) 0.76
Acoustic startle response in panic disorder. Psychiatry Res (2010) 0.76
Smoking, physical activity and respiratory irregularities in patients with panic disorder. Riv Psichiatr (2013) 0.75
The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: an open study. J Clin Psychopharmacol (2003) 0.75
Vulnerability to 35% CO2 of panic disorder patients with a history of respiratory disorders. Psychiatry Res (2003) 0.75
Are gender differences in antiobsessional response related to different clomipramine metabolism? J Clin Psychopharmacol (2002) 0.75
Factors of risk and maintenance for eating disorders: psychometric exploration of the cross-cultural questionnaire (CCQ) across five European countries. Clin Psychol Psychother (2010) 0.75
Bulimia nervosa, 5-HTTLPR polymorphism and treatment response to four SSRIs: a single-blind study. J Clin Psychopharmacol (2004) 0.75
CyberEurope. Cyberpsychol Behav (2009) 0.75
Carbon dioxide-induced panic attacks and quantitative electroencephalogram in panic disorder patients. World J Biol Psychiatry (2010) 0.75
Associations of individual and family eating patterns during childhood and early adolescence: a multicentre European study of associated eating disorder factors. Br J Nutr (2008) 0.75
Emotional intelligence in panic disorder. Riv Psichiatr (2011) 0.75
Language of dyspnea in panic disorder. Depress Anxiety (2004) 0.75
Temperament, character and anxiety sensitivity in panic disorder: a high-risk study. Psychopathology (2012) 0.75